06/17/2026
GLP‑1 medications may be doing more than helping with weight.
New research shows 30% lower odds of breast cancer among overweight and obese women using GLP‑1s. 🧫💉
This doesn’t prove causation — but it adds to growing evidence that metabolic health may influence cancer biology in meaningful ways. 🔬
So many patients ask us about this connection — and the science is evolving quickly. 📈
Save this post to follow the full series.
Does this surprise you? Tell us your thoughts below.
Post 2 drops soon — don’t miss it.
Reference link: https://www.epocrates.com/online/article/asco-2026-glp-1s-tied-to-30-lower-odds-of-breast-cancer